XBKK
WPH
Market cap129mUSD
Nov 12, Last price
6.10THB
Name
Wattanapat Hospital Trang PCL
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Wattanapat Hospital Trang Public Company Limited is a healthcare provider managing a network of hospitals and clinics across Thailand. Its comprehensive medical facilities deliver a broad spectrum of specialized services, encompassing areas such as obstetrics and gynecology, various surgical procedures, internal medicine, pediatrics, neurology, cardiology, ophthalmology, and otolaryngology (ENT). Furthermore, the company offers dermatology and aesthetic treatments, dental services, a dedicated wellness center, and sophisticated diagnostic imaging capabilities including X-ray and MRI. Emergency care is readily available through both its WPH-branded and general emergency centers. Specialized clinics are also provided for conditions related to kidney and hemodialysis, physical therapy, gastroenterology, orthopedics, and endocrinology (diabetes and thyroid disorders). Established in 1957, the organization maintains its headquarters in Trang, Thailand.
Key people
Amara Leelawat
Non-Executive Vice Chairman of the Board · since 2023
Pichapa Boonsontisuk
Assistant Deputy Chief Executive Officer, Assistant Vice President, Executive Director, Member of the Executive Board · since 2023
Somchai Chansawang
Chief Executive Officer, Executive Director, Member of the Executive Board · since 2024
Chane Laosonthorn
Executive Vice President, Executive Director, Member of the Executive Board · since 2023
Sukit Phalanchai
Member of the Executive Board, Deputy Hospital Director - Ancillary · since 2024
Tipparat Khaimarn
Company Secretary · since 2023
Pornlert Boonsontisuk
Non-Executive Director · since 2023
Pinit Laosonthorn
Non-Executive Director · since 2023
Jariya Leelawat
Non-Executive Director · since 2023
Vit Leelawat
Non-Executive Director · since 2023
Chollada Suwanmongkol
Non-Executive Director · since 2023
Dhajjai Subhapholsiri
Non-Executive Independent Chairman of the Board · since 2023
Wichit Chorchieng
Non-Executive Independent Director · since 2023
Wilada Supitak
Non-Executive Independent Director · since 2023
Prateep Vanichkawgul
Non-Executive Independent Director · since 2023
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||